Klotho Neurosciences Files 8-K
Ticker: GRMLW · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1907223
Sentiment: neutral
Topics: 8-K, disclosure, corporate-filing
TL;DR
Klotho Neurosciences filed a standard 8-K, no major news.
AI Summary
Klotho Neurosciences, Inc. filed an 8-K on July 10, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp., is incorporated in Delaware and headquartered in Omaha, NE. This filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by Klotho Neurosciences, Inc., providing updates on their regulatory disclosures and financial statements.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, with no indication of significant events or financial changes.
Key Players & Entities
- Klotho Neurosciences, Inc. (company) — Registrant
- ANEW Medical, Inc. (company) — Former company name
- Redwoods Acquisition Corp. (company) — Former company name
- July 10, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Klotho Neurosciences, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 10, 2025.
What were Klotho Neurosciences, Inc.'s previous names?
Klotho Neurosciences, Inc. was formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp.
In which state is Klotho Neurosciences, Inc. incorporated?
Klotho Neurosciences, Inc. is incorporated in Delaware.
What is the principal business address of Klotho Neurosciences, Inc.?
The principal business address of Klotho Neurosciences, Inc. is 13576 Walnut Street, Suite A, Omaha, NE 68144.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).